Lysosomal damage in various phases of mouse viral hepatitis.
D000135:Acid Phosphatase / Q000378:metabolism*; D000818:Animals; D002403:Cathepsins / Q000378:metabolism*; D005966:Glucuronidase / Q000378:metabolism*; D006520:Hepatitis, Animal / Q000201:enzymology*; D007274:Injections, Intraperitoneal; D008099:Liver / Q000201:enzymology*; D008247:Lysosomes / Q000201:enzymology*; D051379:Mice; D006517:Murine hepatitis virus; D010539:Permeability; D012260:Ribonucleases / Q000378:metabolism*; D013429:Sulfatases / Q000378:metabolism*; D013501:Surface-Active Agents
D013501:Surface-Active Agents; D012260:Ribonucleases; D000135:Acid Phosphatase; D013429:Sulfatases; D005966:Glucuronidase; D002403:Cathepsins